| Mrs Dima Hadidi, | |
|
475 N Farnsworth Ave, Aurora, IL 60505-3004 | |
| (630) 820-3360 | |
| Not Available |
| Full Name | Mrs Dima Hadidi |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 475 N Farnsworth Ave, Aurora, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922593839 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 051.300093 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Dima Hadidi, 1121 W Washburne Ave Unit 201, Chicago, IL 60608-2085 Ph: (716) 361-5649 | Mrs Dima Hadidi, 475 N Farnsworth Ave, Aurora, IL 60505-3004 Ph: (630) 820-3360 |
News Archive
CSL Behring today announced that the U.S. Food and Drug Administration (FDA) has accepted for standard review its Biologics License Application (BLA) for a human 4-factor prothrombin complex concentrate (PCC) for the urgent reversal of vitamin K-antagonist therapy (i.e., warfarin) in patients with acute major bleeding. If approved by the FDA, the CSL Behring 4-factor PCC would be the first agent of its kind available in the United States.
Watson Pharmaceuticals, Inc. today announced an exclusive, worldwide licensing agreement with Itero Biopharmaceuticals, Inc., a venture-backed specialty biopharmaceutical company, to develop and commercialize Itero's Recombinant Follicle Stimulating Hormone. The product is currently in preclinical development as a biosimilar molecule for the treatment of female infertility.
The Associated Press reports that, although health care spending may have slowed, the trend may not last long. In the meantime, The Arizona Republic reports on a website that allows consumers to shop for discounted medical services.
In response to the growing opioid crisis, several states, including Massachusetts and Rhode Island, have granted pharmacists the authority to provide naloxone rescue kits without a prescription to at-risk patients. This model of pharmacy-based naloxone (PBN) education and distribution is one of the public health strategies currently being evaluated at hundreds of pharmacies in both states to determine the impact on opioid overdose death rates.
› Verified 5 days ago
Dr. Binh T Dinh, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1207 N Randall Rd, Aurora, IL 60506 Phone: 630-897-7112 | |
Mr. Minal Samir Patel, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1221 N Lake St, Aurora, IL 60506 Phone: 630-264-6269 | |
Christina Cross, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1157 N Eola Rd, Aurora, IL 60502 Phone: 815-600-4763 | |
Mr. Mohamad Kasar, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2919 Shelly Ln, Aurora, IL 60504 Phone: 630-854-5666 | |
David Bruce Hauge, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2986 Kirk Rd, Aurora, IL 60502 Phone: 847-375-0570 | |
Jimit Baxi, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2986 Kirk Road, Aurora, IL 60502 Phone: 630-375-0570 | |
Sonia K Anderson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9 N Union St, Aurora, IL 60505 Phone: 630-585-7594 Fax: 630-585-7620 |